1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 45 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2014Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjectsTrahair, L.; Horowitz, M.; Hausken, T.; Feinle-Bisset, C.; Rayner, C.; Jones, K.
2013Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humansWu, T.; Bound, M.; Standfield, S.; Bellon, M.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2015The duodenal glucose load impacts the oral disposition index in healthy subjectsMarathe, C.; Feinle-Bisset, C.; Pilichiewicz, A.; Lange, K.; Jones, K.; Rayner, C.; Kahn, S.; Horowitz, M.
2006An update on autonomic neuropathy affecting the gastrointestinal tractPhillips, L.; Rayner, C.; Jones, K.; Horowitz, M.
2013Mechanisms and clinical efficacy of lixisenatide for the management of type 2 DiabetesHorowitz, M.; Rayner, C.; Jones, K.
2003Nutrition therapy for diabetic gastroparesisGentilcore, D.; O'Donovan, D.; Jones, K.; Horowitz, M.
2012The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled studyStevens, J.; Horowitz, M.; Deacon, C.; Nauck, M.; Rayner, C.; Jones, K.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.

Discover